According to statistics from the World Health Organization, in 2014, 1186 cases of prostate cancer were newly emerged in Malaysia. As one of the most common malignant tumor in men, the incidence and mortality of prostate cancer have been on the rise in recent years. Can prostate cancer be treated? Minimally invasive therapy featuring few side effects, small trauma and quick recovery prevents prostate cancer patient from suffering surgery and side effects of chemotherapy and radiotherapy as well as extend their survival time.
If you are diagnosed as Prostate Cancer, please make online appointment or contact us at +86-020-22221111 Ext:3333 to have a consultation.
Advanced Prostate Cancer Patient Shares His Experience against Cancer
SOMPORN NA PHATTHALUNG
Classification of Prostate Cancer
Prostate Cancer can be divided into several categories: Adenocarcinoma, ductal adenocarcinoma, urothelial carcinoma, squamous cell carcinoma, adenosquamous carcinoma. Among them, prostate adenocarcinoma accounts for more than 95%. Therefore, prostate cancer usually refers to prostate adenocarcinoma.
Interpretation of Prostate Cancer Pathology Report
If you want to know more about prostate cancer treatment, Make online appointment or call at +86-020-22221111 Ext:3333 for expert consultation.
Prostate Cancer Stages and 5-year Relative Survival Rate
Prostate Cancer Stage I: 90-95%;
Prostate Cancer Stage II: 60-70%;
Prostate Cancer Stage III: 30-40%;
Prostate Cancer Stage IV: 20%.
Prostate Cancer didn’t show any symptom in early stage, 80% of prostate cancer patients are diagnosed in advanced stage and have poor prognosis. Therefore, Early detection is one of crucial factors for prostate cancer treatment.
Treatment for Prostate Cancer
• Torturous Traditional Anticancer Technology
Operation: Big trauma and high risk; only suitable for early stage prostate cancer; cause serious damage to adjacent tissues and intestine, complications such as urinary incontinence, may even lead to infertility,
Radiotherapy and Chemotherapy: Unbearable toxic side effects, such as hair losing, vomiting and hypoimmunity etc. Chemoradiotherapy fails to achieve good efficacy for patient with advanced prostate cancer wit high chance of recurrence.
• Improve the Survival Rate of Prostate Cancer with New Technology
Minimally Invasive Therapy: 2-3mm incision, few side effects, little pain
Interventional Therapy: With 1-2 mm incision, local administration of drug, the drug concentration of interventional therapy is 2-8 times higher than that of systemic chemotherapy. It kills cancer cells more effectively with few toxic side effects.
Cryotherapy: Cryotherapy reduces the risks and complications from surgery. It also overcome the limitations of anesthesia and avoids the side effects of chemotherapy. Currently, this therapy has been successfully applied to numerous prostate cancer patients and able to obtain a great result.
Particle Implantation: These implanted 125I seeds will keep emitting y-ray within the tumor, targeting to the cancer cells accurately; the radiation of seeds to tumor lasts for 180 days, high accuracy, millimeter minimally invasive; few toxic side effects and complications.
Nanoknife: High voltage pulses released from electrode probes, resulting in multiple permanent nano-meters Irreversible Electroporation, breaking through cancer cells, accurately destroys cancer cells, protects blood vessels and nerves around the lesion, enhances the body's immune mechanism, rapidly metabolizes dead cancer cells and prevents recurrence.
Combination of Traditional Chinese Medicine & Western Medicine: Combining with advantages of traditional Chinese medicine and western medicine, tumor cells will be directly wiped out accurately and powerfully. also maximally reduces patient’s physical hurt due to treatment.
If you want to know more about cancer treatment, we are here to offer help. Make online appointment or call +86-020-22221111 Ext:3333 for expert consultation.
Five advantages of treating Prostate Cancer in St. Stamford Modern Cancer Hospital Guangzhou
Nursing and Diet for Prostate Cancer Patients